Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2025.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2025.
Pharmacy: nonprescription diabetes test devices.
Require insurance coverage of continuous glucose monitoring supplies
Revise insurance laws relating to continuous glucose monitors and supplies
Reducing copay cap on insulin and devices and permitting purchase of testing equipment without prescription
Relating to health benefit plan coverage for certain equipment and supplies associated with diabetes treatment.
Relating to health benefit plan coverage for certain equipment and supplies associated with diabetes treatment.